Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low Dose Versus High Dose Heparin With or Without Hemostasis Patch and Radial Access Site Outcomes; an Open-label Factorial Randomized Trial (InnoSEAL III)

NCT05591872 is registered in ClinicalTrials.gov with Tabba Heart Institute as lead sponsor.

NCT NCT05591872
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05591872 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low Dose Versus High Dose Heparin With or Without Hemostasis Patch and Radial Access Site Outcomes; an Open-label Factorial Randomized Trial (InnoSEAL III)
Lead sponsor
Tabba Heart Institute
Phase
Phase 3
Overall status
Unknown status
Start date
May 9, 2022
Completion date
October 31, 2023
Enrollment
800 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

radial artery occlusion